The CA242 Biomarker for Cancer Detection is a crucial tool in diagnosing and monitoring gastrointestinal cancers, including pancreatic and colorectal cancers. This glycoprotein biomarker is often measured in serum to assess disease progression and treatment efficacy. Its specificity and sensitivity make it a valuable component in clinical diagnostics, aiding in early detection and improving patient outcomes.